S-2367
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for S-2367, covering 2018-05-11 to 2018-05-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet [Phase 2]